IE58626B1 - Monoclonal antibody stabilization - Google Patents

Monoclonal antibody stabilization

Info

Publication number
IE58626B1
IE58626B1 IE196485A IE196485A IE58626B1 IE 58626 B1 IE58626 B1 IE 58626B1 IE 196485 A IE196485 A IE 196485A IE 196485 A IE196485 A IE 196485A IE 58626 B1 IE58626 B1 IE 58626B1
Authority
IE
Ireland
Prior art keywords
day
ovalbumin
monoclonal antibody
theophylline
hydrolyzed
Prior art date
Application number
IE196485A
Other languages
English (en)
Other versions
IE851964L (en
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of IE851964L publication Critical patent/IE851964L/en
Publication of IE58626B1 publication Critical patent/IE58626B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/577—Immunoassay; Biospecific binding assay; Materials therefor involving monoclonal antibodies binding reaction mechanisms characterised by the use of monoclonal antibodies
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5306—Improving reaction conditions, e.g. reduction of non-specific binding, promotion of specific binding
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/825—Pretreatment for removal of interfering factors from sample
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/826—Additives, e.g. buffers, diluents, preservatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IE196485A 1984-08-09 1985-08-08 Monoclonal antibody stabilization IE58626B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/639,156 US4650772A (en) 1984-08-09 1984-08-09 Monoclonal antibody stabilization

Publications (2)

Publication Number Publication Date
IE851964L IE851964L (en) 1986-02-09
IE58626B1 true IE58626B1 (en) 1993-10-20

Family

ID=24562959

Family Applications (1)

Application Number Title Priority Date Filing Date
IE196485A IE58626B1 (en) 1984-08-09 1985-08-08 Monoclonal antibody stabilization

Country Status (15)

Country Link
US (1) US4650772A (https=)
EP (1) EP0170983B1 (https=)
JP (1) JPH0699325B2 (https=)
KR (1) KR900002652B1 (https=)
AT (1) ATE57021T1 (https=)
AU (1) AU592952B2 (https=)
CA (1) CA1238284A (https=)
DE (1) DE3579868D1 (https=)
DK (1) DK333185A (https=)
ES (1) ES8702790A1 (https=)
GR (1) GR851926B (https=)
IE (1) IE58626B1 (https=)
IL (1) IL75762A (https=)
NZ (1) NZ212694A (https=)
ZA (1) ZA855248B (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ217844A (en) * 1985-10-11 1989-10-27 Sumitomo Pharma A sustained release pharmaceutical composition containing silicone elastomer and an albumin
DE3877015T2 (de) * 1987-02-20 1993-05-06 Akzo Nv Antikoerper enthaltende stabilisierte waesserige zusammensetzung.
US5237054A (en) * 1987-02-20 1993-08-17 Akzo Pharma Stabilized aqueous composition containing antibodies
DE3825429C2 (de) * 1988-07-27 1994-02-10 Biotest Pharma Gmbh Verfahren zur Herstellung eines intravenös verabreichbaren polyklonalen Immunglobulin-Präparates mit hohem IgM-Gehalt
JP2627681B2 (ja) * 1990-07-18 1997-07-09 同仁医薬化工株式会社 マイコプラズマ・ニューモニエ診断用試薬
WO1992001808A1 (fr) * 1990-07-18 1992-02-06 Dojin Iyaku-Kako Co., Ltd. Reactif permettant de diagnostiquer mycoplasma pneumoniae
JPH0565233A (ja) * 1991-03-08 1993-03-19 Mitsui Toatsu Chem Inc モノクローナル抗体含有凍結乾燥製剤
JP2553445B2 (ja) * 1992-12-17 1996-11-13 同仁医薬化工株式会社 抗体の安定化方法
EP0852951A1 (de) 1996-11-19 1998-07-15 Roche Diagnostics GmbH Stabile lyophilisierte pharmazeutische Zubereitungen von mono- oder polyklonalen Antikörpern
AU2006247039B2 (en) * 2005-05-19 2011-03-03 Amgen Inc. Compositions and methods for increasing the stability of antibodies
WO2011093745A1 (en) * 2010-01-26 2011-08-04 Obschestvo S Ogranichennoi Otvetstvennostyu "Nauchno- Proizvodstvennaya Firma "Materia Medika Kholding" Method of determination of autoantibody level by means of enzyme immunoassay

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5816471B2 (ja) * 1977-11-29 1983-03-31 持田製薬株式会社 免疫化学的測定試薬の安定化剤
US4444880A (en) * 1982-07-27 1984-04-24 Syva Company Periodate removal of ascorbate interference in dipsticks for immunoassays
US4439421A (en) * 1982-08-30 1984-03-27 Baxter Travenol Laboratories, Inc. Stabilized gamma globulin concentrate
US4482483A (en) * 1983-04-06 1984-11-13 Armour Pharmceutical Company Composition of intravenous immune globulin

Also Published As

Publication number Publication date
ATE57021T1 (de) 1990-10-15
EP0170983A3 (en) 1988-01-27
KR860001594A (ko) 1986-03-20
CA1238284A (en) 1988-06-21
ES545975A0 (es) 1987-01-16
JPS6176423A (ja) 1986-04-18
US4650772A (en) 1987-03-17
IL75762A (en) 1989-10-31
GR851926B (https=) 1985-12-09
ZA855248B (en) 1986-02-26
DE3579868D1 (de) 1990-10-31
ES8702790A1 (es) 1987-01-16
EP0170983A2 (en) 1986-02-12
NZ212694A (en) 1988-05-30
KR900002652B1 (ko) 1990-04-21
EP0170983B1 (en) 1990-09-26
AU592952B2 (en) 1990-02-01
DK333185D0 (da) 1985-07-22
JPH0699325B2 (ja) 1994-12-07
IL75762A0 (en) 1985-11-29
DK333185A (da) 1986-02-10
AU4536985A (en) 1986-02-13
IE851964L (en) 1986-02-09

Similar Documents

Publication Publication Date Title
Avrameas et al. Glutaraldehyde, cyanuric choloride and tetraazotiexe O-dianisidine as coupling reagents in the passive hemagglutination test
Lambrechts et al. The mammalian profilin isoforms display complementary affinities for PIP2 and proline‐rich sequences
Leberer et al. Immunochemical quantification of sarcoplasmic reticulum Ca‐ATPase, of calsequestrin and of parvalbumin in rabbit skeletal muscles of defined fiber composition
Cardenas et al. Bovine Pyruvate Kinases: I. PURIFICATION AND CHARACTERIZATION OF THE SKELETAL MUSCLE ISOZYME
White et al. Direct demonstration of increased intracellular concentration of free calcium as measured by quin-2 in stimulated rat peritoneal mast cell.
Moczydlowski et al. Characterization of 2', 3'-O-(2, 4, 6-trinitrocyclohexadienylidine) adenosine 5'-triphosphate as a fluorescent probe of the ATP site of sodium and potassium transport adenosine triphosphatase. Determination of nucleotide binding stoichiometry and ion-induced changes in affinity for ATP.
Poston A buffered chromic chloride method of attaching antigens to red cells: use in haemagglutination
Inagaki et al. Naphthalenesulfonamides as calmodulin antagonists and protein kinase inhibitors.
EP0170983B1 (en) Monoclonal antibody stabilization
Kobayashi et al. Ca2+ regulated modulator protein interacting agents: Inhibition of Ca2+ Mg2+-ATPase of human erythrocyte ghost
Cummins et al. Myosin transitions in the bovine and human heart. A developmental and anatomical study of heavy and light chain subunits in the atrium and ventricle.
McCans et al. Antigenic differences in (Na+, K+)-ATPase preparations isolated from various organs and species.
Le Peuch et al. Calcium and cyclic nucleotide dependent regulatory mechanisms during development of chick embryo skeletal muscle
Thiele et al. Formation and immunological properties of aldehyde-derived protein adducts following alcohol consumption
O'Rourke et al. Release of Ca2+ by inositol 1, 4, 5-trisphosphate in platelet membrane vesicles is not dependent on cyclic AMP-dependent protein kinase
Knott et al. In vitro motility analysis of thin filaments from failing and non-failing human heart: troponin from failing human hearts induces slower filament sliding and higher Ca2+ sensitivity
Holmgren et al. Immunochemistry of Thioredoxin: I. PREPARATION AND CROSS-REACTIVITY OF ANTIBODIES AGAINST THIOREDOXIN FROM ESCHERICHIA COLI AND BACTERIOPHAGE T4
Heilmeyer Jr et al. Novel aspects of skeletal muscle protein kinase and protein phosphatase regulation by Ca2+
Sartori et al. MAPKinase and regulation of the sodium–proton exchanger in human red blood cell
Damiani et al. Common structural domains in the sarcoplasmic reticulum Ca-ATPase and the transverse tubule Mg-ATPase.
Bartles et al. Slime mold lectins
US4330620A (en) Method and reagent for the determination of creatine kinase MB
Kohler et al. Detection of recombinant growth hormone in human plasma by a 2‐D PAGE method
Ueno et al. Isolation and partial characterization of a 110-kD dimer actin-binding protein.
Olwin et al. Immunoaffinity purification and characterization of 5-[[[(iodoacetyl) amino] ethyl] amino] naphthalene-1-sulfonic acid-derivatized calmodulin

Legal Events

Date Code Title Description
MM4A Patent lapsed